Epistem's Biomarker Division Receives GCLP Accreditation | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK biotech Epistem said today its Biomarker Division has received Good Clinical Laboratory Practice accreditation status.

The company said in a statement that the accreditation allows it to support later phases of drug development, and that all studies will be conducted to meet GCLP standards established by the British Association of Research Quality Assurance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.